Oral Contraceptive Use Modifies the Manifestations of Pelvic Inflammatory Disease

Pål Wölner‐Hanssen
In: Obstetrical & Gynecological Survey · 1987 · vol. 42(2) , pp. 125–126 · doi:10.1097/00006254-198742020-00023 · W4249328693
article OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-26 ⓘ

This study investigated how oral contraceptive use modifies the clinical manifestations of pelvic inflammatory disease, providing insights relevant to gynecological health conditions including endometriosis and adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Department of Obstetrics and Gynecology, University Hospital, Lund, Sweden Br. J. Obstet. Gynecol. 93: 619, 1986

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK